Stents, scaffolds and DCB

Latest Stents, scaffolds and DCB content in interventional cardiology - research, practice, and education

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

505 results

Simplify PCI! Know where and how to win with drug-coated balloon

22 May 2025 – From EuroPCR 2025

This session provides a comprehensive update on the use of drug-coated balloons (DCBs) to simplify percutaneous coronary intervention (PCI). It reviews various types of drugs, coatings, and balloon technologies used in DCBs, alongside the latest clinical data supporting their safety and efficacy. It also offers practical insights into...

Simplify PCI! Know where and how to win with drug-coated balloon

Transforming PCI: mastering the implementation of drug-eluting balloons

22 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session provides a comprehensive overview of drug-eluting balloons (DEBs) and their growing role in percutaneous coronary intervention (PCI). Gain a clear understanding of the clinical evidence and rationale supporting DEBs, including how these devices minimize metal implantation and effectively treat both standard and...

Transforming PCI: mastering the implementation of drug-eluting balloons

Treating complex CAD indications with sirolimus coated balloon: evidence and performance

22 May 2025 – From EuroPCR 2025

Gain a deeper understanding of how sirolimus coated balloon (SCB) technology is shaping the treatment of complex coronary artery disease (CAD). This EuroPCR 2025 session brings together compelling clinical trial data and real-world case presentations to illustrate the safety, efficacy, and versatility of the MagicTouch SCB...

Treating complex CAD indications with sirolimus coated balloon: evidence and performance

Integration of CT and IVUS for treatment of coronary artery disease in daily practice: from planning to drug-eluting therapy

22 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session highlights how imaging can drive precision in modern PCI. From CT-guided planning to IVUS-guided drug-eluting balloon interventions, each presentation offers practical insights into optimising patient outcomes. Step-by-step approaches and recorded cases illustrate how to tailor tool and technique selection, while also addressing...

Integration of CT and IVUS for treatment of coronary artery disease in daily practice: from planning to drug-eluting therapy

Left main and complex bifurcation stenting

22 May 2025 – From EuroPCR 2025

In this EuroPCR 2025 session, discover best practices for managing left main and challenging bifurcation lesions, from choosing a stepwise provisional side branch stenting strategy to using intracoronary imaging and physiology to guide and optimise PCI results.

Learn how the Ultimaster Nagomi™ sirolimus-eluting stent system builds on...

Left main and complex bifurcation stenting

DCB and latest DES technology for coronary interventions

22 May 2025 – From EuroPCR 2025

Explore the latest in drug-coated balloon (DCB) and drug-eluting stent (DES) technology for coronary interventions. Review predictors of angiographic outcomes, trial data comparing DCB and DES, and insights into treating calcified lesions and bifurcation disease with novel devices.

DCB and latest DES technology for coronary interventions

Through decisions in complex left main PCI – Left main trifurcation

22 May 2025 – From EuroPCR 2025

This session offers an in-depth analysis of complex left main trifurcation PCI, covering evaluation through imaging and physiology, lesion preparation strategies, and treatment options including stepwise provisional approaches, upfront two-stent techniques, and drug-coated balloons.

Through decisions in complex left main PCI – Left main trifurcation

Which device for which patient: DES, BRS or DCB?

22 May 2025 – From EuroPCR 2025

This session provides comprehensive guidance on selecting the appropriate device—DES, BRS, or DCB—for individual patients and lesions. It examines patient and lesion characteristics, strengths and limitations of each device type, and regional considerations, illustrated by case presentations demonstrating practical device choice and resolution.

Which device for which patient: DES, BRS or DCB?

Procedural aspects of DCB PCI

22 May 2025 – From EuroPCR 2025

Delve into procedural aspects of drug-coated balloon (DCB) PCI with a focus on lesion preparation, antiplatelet therapy, and outcomes in real-world settings. This session reviews the impact of pre-dilatation balloons on de novo lesions, compares ticagrelor versus clopidogrel post-PCI with drug-eluting balloons, and discusses streamlined revascularization...

Procedural aspects of DCB PCI

The calcium challenge: stent avoidance and in-stent restenosis treatment

22 May 2025 – From EuroPCR 2025

Confront the challenges posed by coronary calcium through innovative stent avoidance and in-stent restenosis treatment strategies. This session features analyses on the feasibility of intravascular lithotripsy (IVL) alone, its use prior to drug-coated balloon angioplasty, and in treating in-stent restenosis. Outcomes following IVL-assisted PCI are reviewed...

The calcium challenge: stent avoidance and in-stent restenosis treatment